Tag
The FDA recently approved a new blood test for Alzheimer’s that researchers say helps doctors diagnose it earlier and at…

Recent research revealed that blood tests for biomarkers of Alzheimer’s are less reliable for Black patients than for other racial…

At HJ25 in L.A., Charles Piller spoke about his book delving into the world of Alzheimer’s research misconduct.

In this webinar, we speak with an investigative journalist and neuroscientist who uncovered widespread Alzheimer’s research misconduct.

Reporters Jeanne Lenzer and Shannon Brownlee discuss their latest work, a three-part series on industry influence at the FDA.

New research on high-density lipoprotein cholesterol may give us more insight into factors that affect cognitive health in aging adults.

•
In this webinar, we’ll speak with an investigative journalist and neuroscientist who uncovered widespread Alzheimer’s research misconduct.

Science reporter Charles Piller discusses how he discovered evidence of a prominent neuroscientist’s research misconduct.

A blockbuster story in The BMJ showed major concerns surrounding the approval process, efficacy and safety of the Alzheimer’s drug…

Learn how two investigative journalists uncovered a trove of information about the recently approved Alzheimer’s drug donanemab.
